By: Susan Schniepp, Distinguished Fellow, Regulatory Compliance Associates Inc.   The US Food and Drug Administration (FDA) has recently expanded on its clarification of a virtual audit, and how new manufacturing protocols in the COVID-19 environment will evolve. Travel constraints continue to impact the industry, especially in countries like India where a tremendous outbreak of … Continue reading FDA Expands Virtual Audit Guidance